Identified during 1st online questionnaire (short), 2nd online questionnaire (detailed) or call with symptoms.
Patients directed to local pathway - See current advice for eligibility:
Patients with high risk and moderate symptoms are managed by the LHD according to local pathways.
This may include increased monitoring, involvement of patient's specialists.
Immunosuppressed, including:
Serious chronic health problems including heart, lung, kidney, brain, nerves or muscles, metabolic:
Severe obesity in children, indicated by weight over 99th percentile for age or Type 2 Diabetes (treated with oral medication)
Moderate Symptoms (also advised to contact their usual doctor if moderate symptoms)
and
Serious chronic health problems (including heart, lung, kidney, brain, nerves or muscles, metabolic), for example:
or
Severe asthma, as indicated by:
NSW Agency for Clinical Innovation
COVID Care in the Community Subject Matter Expert Reference Group.
Dr Nigel Lyons, Deputy Secretary, Health System Strategy and Planning, NSW Ministry of Health.
NSW Health local health districts, specialty health networks and primary health care